News for Bio-Rad Laboratories, Inc. (BIO-B)

Published at

Mar 5, 2025 6:00 AM

by insidermonkey.com

positive

positive

Is Bio-Rad Laboratories, Inc. (BIO) the Best Medical Technology Stock to Buy According to Analysts?

We recently compiled a list of the 7 Best Medical Technology Stocks To Buy According To Analysts. In this article, we are going to take a look at where Bio-Rad Laboratories, Inc.

BUWA.DE BIO-B BIO

Read more →
Published at

Feb 26, 2025 2:38 AM

by manilatimes.net

mixed

mixed

Liquid Biopsy Market Worth US$11.3 billion at a robust CAGR of 11.9% | MarketsandMarkets™.

**media[550320]**

NTRA TMO.MX TMO SSMXY SSMXF PSNL MYGN MYD.DE LLAI.L LH.MX LH L1CA34.SA ILU.DE ILMN.MX ILMN I1LM34.SA EXAS EPGNY EPGNF ECX.DE BUWA.DE BIO-B BIO ANPCY ANPCF AGL.L 6869N.MX 6869.T 0R0H.L 0K3W.L 0JSY.L 0J8Z.L

Read more →
Published at

Feb 14, 2025 6:43 PM

by gurufocus.com

neutral

neutral

Bio-Rad Laboratories Inc (BIO) Stock Price Down 9.91% on Feb 14

Shares of Bio-Rad Laboratories Inc (BIO) fell 9.91% in mid-day trading on Feb 14. The stock reached an intraday low of $275.99, down from its previous close o

BUWA.DE BIO-B BIO

Read more →
Published at

Feb 14, 2025 5:45 AM

by seekingalpha.com

neutral

neutral

Bio-Rad Laboratories, Inc. (BIO) Q4 2024 Earnings Call Transcript

Bio-Rad Laboratories, Inc. (NYSE:BIO) Q4 2024 Earnings Conference Call February 13, 2025 5:00 PM ETCompany ParticipantsEdward Chung - Vice President of...

BUWA.DE BIO-B BIO

Read more →
Published at

Feb 13, 2025 11:45 PM

by zacks.com

negative

negative

Bio-Rad Laboratories (BIO) Misses Q4 Earnings and Revenue Estimates

Bio-Rad (BIO) delivered earnings and revenue surprises of -1.02% and 1.07%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

BIO-B BIO

Read more →
Published at

Feb 12, 2025 1:20 PM

by gurufocus.com

positive

positive

Bio-Rad Laboratories Inc (BIO) Q4 2024 Earnings Report Preview: What To Look For

Bio-Rad Laboratories Inc (BIO) is set to release its Q4 2024 earnings on Feb 13, 2025. The consensus estimate for Q4 2024 revenue is $679.30 million, and the ea

BUWA.DE BIO-B BIO

Read more →
Published at

Feb 6, 2025 4:00 PM

by zacks.com

neutral

neutral

Earnings Preview: Bio-Rad Laboratories (BIO) Q4 Earnings Expected to Decline

Bio-Rad (BIO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

BIO-B BIO

Read more →
Published at

Jan 28, 2025 8:41 PM

by insidermonkey.com

positive

positive

Bio-Rad Laboratories, Inc. (BIO): Is This Healthcare Stock A Good Buy?

We recently compiled a list of the Retirement Stock Portfolio: 10 Healthcare Stocks to Buy. In this article, we are going to take a look at where Bio-Rad Laboratories, Inc.

BUWA.DE BIO-B BIO

Read more →
Published at

Jan 7, 2025 12:00 PM

by gurufocus.com

neutral

neutral

Biodesix Announces Publication of a New Nodify CDT® Clinical Validation Study

Analysis of 447 patients receiving the Nodify CDT blood-based lung nodule test published in CHEST Pulmonary Journal reaffirms test performance LOUISVILLE, Col

BUWA.DE BIO-B BIO BDSX

Read more →
Published at

Jan 6, 2025 6:06 PM

by gurufocus.com

positive

positive

Bio-Rad Laboratories Inc (BIO) Shares Up 4.06% on Jan 6

Shares of Bio-Rad Laboratories Inc (BIO) surged 4.06% in mid-day trading on Jan 6. The stock reached an intraday high of $345.03, before settling at $344.17,

BUWA.DE BIO-B BIO

Read more →
Published at

Jan 2, 2025 11:02 PM

by gurufocus.com

positive

positive

Bio-Rad Laboratories Inc (BIO) to Engage with Analysts and Investors at J.P. Morgan Healthcare Conference

Summary Bio-Rad Laboratories Inc (BIO), a prominent player in life science research and clinical diagnostics, announced that its top executives will participate

BUWA.DE BIO-B BIO

Read more →
Published at

Dec 5, 2024 5:04 PM

by gurufocus.com

neutral

neutral

Bio-Rad Laboratories Inc (BIO) Stock Price Down 3.49% on Dec 5

Shares of Bio-Rad Laboratories Inc (BIO) fell 3.49% in mid-day trading on Dec 5. The stock reached an intraday low of $326.40, before recovering slightly to $

BUWA.DE BIO-B BIO

Read more →
Published at

Nov 25, 2024 7:21 PM

by seekingalpha.com

positive

positive

Why Bio-Rad Laboratories Is Overvalued: A Fundamental And DCF Analysis (NYSE:BIO)

Bio-Rad’s innovation is slowing, with declining patents and negative ROE. See why BIO stock is overvalued by 20.10% and facing challenges in 2024.

BIO-B BIO

Read more →
Published at

Nov 25, 2024 4:00 PM

by gurufocus.com

positive

positive

Agilent Announces New Organizational Structure to Support its Market-Focused Strategy

Agilent Technologies Inc. (NYSE: A) today announced a new organizational structure to accelerate the company's operational transformation to drive higher growt

BIO-B BIO A1GI34.SA A.MX A 0HAV.L

Read more →
Published at

Nov 25, 2024 2:05 AM

by insidermonkey.com

neutral

neutral

Bio-Rad Laboratories, Inc. (BIO): A Bull Case Theory

We came across a bullish thesis on Bio-Rad Laboratories, Inc. (BIO) on Substack by Stock Analysis Compilation. In this article, we will summarize the bulls’ thesis on BIO.

BUWA.DE BIO-B BIO

Read more →
Published at

Nov 22, 2024 3:55 PM

by seekingalpha.com

positive

positive

Franklin Mutual Small-Mid Cap Value Fund Q3 2024 Commentary

US small- and mid-cap equities, as measured by the Russell 2500 Index, rose in the third quarter of 2024.

VCTR UFPI QQ.L QNTQY QNTQF MTT.DE MAT.MX MAT GTLS FSNUY FSNUF FREN.MX FRE.DE BUWA.DE BIO-B BIO 0JZH.L

Read more →
Published at

Nov 21, 2024 4:00 PM

by gurufocus.com

neutral

neutral

Bio-Rad's Management to Host Investor Meetings at Citi's 2024 Global Healthcare Conference

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that the company'

BUWA.DE BIO-B BIO

Read more →
Published at

Nov 16, 2024 12:04 PM

by gurufocus.com

neutral

neutral

Bio-Rad Laboratories Inc (BIO) Shares Down 8.54% on Nov 16

Shares of Bio-Rad Laboratories Inc (BIO) fell 8.54% in mid-day trading on Nov 16. The stock reached an intraday low of $319.25, before recovering slightly to

BUWA.DE BIO-B BIO

Read more →
Published at

Nov 13, 2024 11:24 AM

by medium.com

mixed

mixed

Top Companies In The U.S. Legionella Testing Market

The U.S. Legionella Testing Market Size sector reached a market value of USD 103.6 million in 2022. Future projections show a bright outlook, with a Compound Annual Growth Rate (CAGR) of 9.2% from…

TMO.MX TMO 0R0H.L QDEL.MX QDEL BUWA.DE BIO-B BIO 0A55.L

Read more →
Published at

Nov 13, 2024 11:23 AM

by medium.com

mixed

mixed

Top Companies In The U.S. Point of Care Diagnostics Market

The U.S. Point of Care Diagnostics Market Size sector reached a market value of USD 9.45 billion in 2023. Future projections show a bright outlook, with a Compound Annual Growth Rate (CAGR) of 6.9%…

QDEL.MX QDEL BUWA.DE BIO-B BIO 0A55.L TMO.MX TMO DGX.MX DGX CAHD.BA CAH.MX CAH C1AH34.SA ABTCL.SN ABT.SN ABT 0R0H.L 0KSX.L 0HTG.L

Read more →